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 Chalcones (1,3-diphenylpropen-1-ones), a biosynthetic product of the 
shikimate pathway, belonging to flavanoid family are precursors of open chain 
flavonoids and isoflavonoids, which are abundant in edible plants. These compounds 
have been studied as therapeutics, especially as antitumor drugs. A chalcone 
derivate, para hydroxy metha methoxy chalcone (pHmMC) or 3 - (4'-hydroxy-3'-
methoxyphenyl)-1-phenyl-2-propene-1-on was synthesized by reaction between 
vanillin and acetofenon through cross-aldol condensation reaction under acidic 
conditions.  The aim of this study is to investigate the cytotoxic effect of pHmMC on 
MCF7 breast cancer cells and its mechanism through investigation on apoptosis and 
cell cycle arrest. The cytotoxic effect on MCF-7 was analyzed by MTT [3-4, 5 
dimetiltiazol-2-yl)-2,5difeniltetrazoilium bromide] assay. Flowcytometry method 
was used to determine the influence of pHmMC in the regulation of cell cycle arrest 
and apoptosis.The result showed that the pHmMC inhibited MCF-7 cell growth with 
IC50  40 M. The cytotoxic activity is influenced by the ability of pHmMC to induce 
apoptosis and G2/M arrest.  
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Cancer is a serious public health issue in the world. One of  the most five deadly cancer 
diseases leading patient death is breast cancer (WHO, 2006). In Indonesia, breast cancer is the 
second most frequently cancer in women after cervical cancer (Tjindarbumi and 
Mangunkusumo, 2002). There are several methods of cancer treatment such as surgery, 
radiation, immunotherapy, and chemotherapy (King, 2000). However, the high mortality rate 
indicates the treatments have not overcome the cancer. These problems pushed to find 
compounds for the cancer treatment either comes from natural or synthetic. 
Chalcones, a group of aromatic enones, forms the central core a variaty of important 
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biological compounds obtained from plants. These phenoli compounds all bear a 1,3-diphenyl-
2-en-1-one framework (Bohm, 1998). The synthetic chalcones can be prepared by an aldol 
condensation between a benzaldehyde and acetophenone in the presence of strong bases such as 
NaOH, KOH, Ba(OH)2, hydrotalcites, LiHMDS, calcined NaNO3/natural phosphate. There are 
also some reports of acid-catalized aldol condensations, e.g. AlCl3, BF3, dry HCl, ZrH2/NiCl2 
and RuCl3 (for cyclic and acyclic ketones) ( Rahman, 2011). Chalcones and its derivates have 
attracted increasing attention due to numeorous pharmacological applications. They have 
displayed a broad spectrum of pharmacological activities, one of them as anticancer (Achanta, 
et al., 2006; Romagnoli et al., 2008; Echeverria et al., 2009; Szliszka et a.l, 2010; Ilango et al., 
2010; Arianingrum et al., 2011; Arianingrum et al., 2012).  
A chalcone derivat compound,  pHmMC or 3 - (4'-hydroxy-3'-methoxyphenyl)-1-phenyl-
2-propene-1-on (Figure 1) was synthesized by reaction between vanillin and acetofenon through 
cross-aldol condensation reaction under acidic conditions (Arty, 2010). Previous study has 
reported that this compound induces apoptosis and inhibit phase of the cell cycle through G2/M 
in breast cancer T47D cell line (Arianingrum et al., 2012). In the study, we investigated the 
effect of  pHmMC on cytotoxicity, apoptosis induction and cell cycle of breast cancer MCF-7 
cell lines. This study is useful for further development of pHmMC as medicine in the tratment 





The compound, pHmMK, was obtained from Prof Indyah Sulistyo Arty, Faculty of 
Mathematic and Natural Science, Universitas Negeri Yogyakarta (UNY). This compound was 
synthesized by reacting of vanillin and acetofenon through cross-aldol condensation reaction in 
acidic condition. The compound was diluted in dimethylsulfoxide (DMSO) at the desired 
concentration. The final DMSO concentration was made with concentration of less than 0.2%.  
 
Cells Culture 
MCF7 breast cancer cells were obtained from the collection of Laboratory of 
Parasitology, Faculty of Medicine, Universitas Gadjah Mada (UGM). Cells were grown in 
medium culture DMEM (Dulbecco’s modified Eagle’s Medium) from Gibco contains FBS 
(Fetal Bovine Serum, Gibco) 10% and penicillin-streptomycin 1% (Gibco) at 37oC in 
humidified atmosphere of 5% CO2/95% air. Tripsin-EDTA  0.025% (Gibco) was used to 
detached cells on the flask.  
 
Cytotoxic Assay 
Cytotoxic assay were performed using [3-4, 5 dimetiltiazol-2-yl)-2,5difeniltetrazoilium 
bromide] (MTT) assay. MCF7 cells were seeded at a density of 5 x 103 cells/well and allowed to 
attach for 24 hours. One day after initial seeding, cell were treated with either various 
concentration of pHmMC. After 24 hours of incubation, culture medium was removed and cells 
were washed with Phospate Buffered Saline (PBS) from Sigma. Then, cells were added with 
100 mL MTT (Sigma Chemical, St. Louis, MO, USA) 5 mg/ml diluted with culture medium in 
each well for 4 hours. Stopper reagent , 10%  Sodium dodecyl sulphate or SDS (Sigma) in 0.01 
mol HCl (Merck) was added after formazan formation prior to MTT reduction and incubated for 
12 hours (overnight) at room temperature and protected from light. The absorbance of each well 
was measured using ELISA reader (Bio-Rad) at λ 595 nm. The absorbance was converted to 
percentage of viable cells (Mosmann, 1983). IC50 concentration were calculated by the 
concentration that causes 50% inhibition of cell growth (Doyle and Griffith, 2000). Calculation 
of IC50 values were done using the linear regression of log concentration versus cells viability. 
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Apoptosis  and Cell Cycle Analysis 
MCF7 cells were seeded at 1 x 106 cells/well on six wells tissue culture plate. After 24 
hours incubation cells were treated with pHmMK. After 24 hours of these treatments, cells were 
trypsinized, spin at 2000 rpm for 3 minute, and washed twice with cold PBS. Cells were 
resuspended in 500 L of Annexin V buffer (Roche) and then treated with Annexin V and 
propidium iodide (PI) for 10 minute at room temperature and protected from light. The treated 
cells were subjected to FACScan flowcytometer. Bivariant analysis of FITC-flourosence (FL-1) 
and PI-flouresence (FL-3) gave different cell population where FITC (-) and PI (-) were 
designed as viable cells; FITC (+) and PI (-) phenotype as early apoptotic cells; FITC (-) and PI 
(+) as necrotic cells; and FITC (+) and PI (+) as late apoptotic cells. Cell cycle analysis was 
determined using cycletestTM Plus DNA Reagent Kit (BD Biosciences). Based on DNA 
contents, percentage of cells in each stage of cell cycle (G1, S and G2/M phases) were calculated 
measured using Cellquest programe.  
 
 
RESULT AND DISCUSSION 
Cytotoxic effect of pHmMC on MCF-7 cells 
MTT assay was done to measure cell viability of  MCF-7 due to pHmMC treatment. 
This compound showed growth inhibitory effect in dose dependent manner (Figure 2 A-E). 
Based on morphological appearance and cells viability,  pHmMC  with concentration of  10, 
25,50, 75, 100 and 125 M respectively showed a linear correlation between concentration with 
toxicity effects. The IC50 value of pHmMC was 40 M obtained from the linear regression 
calculation of cell viability versus log concentration with P<0.05. These effect supposed to be 














Figure 2. Cytotoxic effect of pHmMC on MCF-7 cell using MTT assay. Test were carrried out 
by incubating 104 cells in 96 well plates for 24 hours in DMEM medium without or with 
pHmMC treatments (0-125M). Profiles of cell viability expressed mean ± SD of three 
experiments (A). Obvious morphological changes and cell populations in the treatment of 
pHmMC concentrations of  75 M (C) compared with controls (B). Black arrow indicates a 
normal living cell, whereas dashed arrows indicate the cell morphology changes. Cell 
morphology observations conducted using an inverted microscope with 100x magnification.    
Effect of pHmMC on apoptosis induction  
Evaluation of  the impact of pHmMC treatment on apoptosis induction of MCF-7 cells 











serine residues which are normaly located in the internal phospholipid layer to external layer in 
apoptotic cells. The result showed that  pHmMC induced apoptosis rates of early apoptotic cells 
and late apoptotic cells on MCF-7 cells (Figure 3). The percentage of apoptotic cells increased 
after treatment with pHmMC. Increased concentrations of pHmMC lead to more cells 


































Figure 3. Effect of pHmMC on apoptosis induction in MCF-7 cells. The cells were seeded at 
5x105 cells/well on six wells tissue culture plate, then treated with pHmMC concentration of  0,  
½ IC50, IC50, and 1½ IC50. After 24 hours incubation, cell were harvested as described in 
methods, added AnnexinV and PI reagent, then subjected to FACS flowcytometer. 
Flowcitometric profile of cells treatment with 0 or control (A), 20 (B), 40 (C), and 60 (D) M 
respectively. There are 4 quadrans : lower left (R1) marked in blue indicates viable cells, lower 
right (R2) marked in green indicates early apoptotic cells, upper right (R3) marked in orange 
indicates late  apoptotic cells and upper left (R4) marked in yellow indicates necrotic cells. 
Graph (E) showed that pHmMC induced apoptosis. 
Effect of pHmMC on cycle cells  
To confirm that treatment of pHmMC increased cell death by modulating cell cycle, we 
evaluated cell cycle profile using flowcytometry method. Treatment with pHmMC induced cells 
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accumulation in G2/M (Table 1).  
 
Table  1.  Percentage of MCF-7 cell at GO-G1, S and G2/M respectively after treatment with 
pHmMC at concentration  20 M.  
 
Sample Persentage MCF-7 cells at phase: (%) 
Go-G1 S G2/M 
Control Cell 61.79 19.48 17.13 
pHmMC  64.89 13.79 19.26 
 
Based on our research, pHmMC showed potent cytotoxic effect with IC50 value of 40 
M. Prayong et al (2008) mentioned that compound with IC50 less than 100 µM is potentially 
developed as anticancer agent. This result showed the potential of pHmMC to be delevoped as 
anti cancer.  
As we know, that cancer cells are able to avoid apoptosis mechanism and cells occurs 
abnormal regulation of the cell cycle. The cytotoxic effect is suggested to be related to apoptotic 
induction and cell cycle modulation. In apoptosis study, in line with cytotoxic study pHmMC 
increased the incidence of cell undergoing apoptosis. Apoptosis is programmed cell death 
characterized by changes on morphology, membrane blebbing and chromatine (Rudin and 
Thomson, 1997). In this study, the morphological change from normal to dead of the cells were 
more extensive after treatment with pHmMC. In the flowcytometry analysis showed that 
treatment with pHmMC at 40 M increased cell death from 5.7% to 18.35%, and increased to 
50.06% after treatment with 60 M pHmMC. These results indicate that this compound is able 
to induce apoptosis.  
The cell cycle analysis was performed by using flowcytometer to observe the 
distribution of cells in each phase of the cell cycle. This method based on DNA content in cells. 
After the cells were incubated with propidium iodide, a red fluorescent DNA will be captured 
by the detector flowcytometer. Cell Cycle consists of proliferative phase, in the resting state (no 
cells divides, Go), and not permanently divide. Cells that are dividing divided into 4 (four) 
major phases: the gap phase 1 (G1), synthesis phase (S), gap phase 2 (G2), and mitosis phase 
(M) (Foster et al., 2001 and Vermeulen et al., 2003). In our research showed that treatment with 
pHmMC influence the cell cycle checkpoint control of MCF-7 by inducing G2/M cell cycle 
arrest. The results of this analysis showed the compound influence on cell cycle checkpoint 
control.  
Based on literature study, the basic structure of chalcone (1,3-diphenyl-2-propenone) 
has proven to have a chemopreventive effect in human breast cancer cell lines: MCF-7 and 
MDA-MB-231 (Hsu et al., 2006) and human bladder cancer cell lines: T24 and HT-1376 (Shen 
et al., 2007). The research showed that chalcone inhibits the proliferation of  T24 and HT-1376 
cells by inducing apoptosis and blocking cell cycle progression in the G2/M phase. Chalcone 
significantly increases the expression of p21 and p27 proteins, and decreases the levels of cyclin 
B1, cyclin A and Cdc2, thereby contributing to cell cycle arrest. In addition, chalcone increased 
the expression of Bax and Bak, but decreased the levels of Bcl-2 and Bcl-XL and subsequently 
triggered mitochondrial apoptotic pathway (release of cytochrome c and activation of caspase-9 
and caspase-3). Chalcone also has NF-kB inhibitor activity at concentration of 50 M (Shen et 
al, 2007). Nuclear factor kappa B (NF-κB) is transcription factors that plays a major role in 
development and progression of cancer because it regulates more than 400 genes involved in 
inflammation, cell survival, cell proliferation, invasion, angiogenesis, apoptosis, cell cycle and 




metastasis (Yadav et al., 2011 and Pahl, 1999). 
Our compound, pHmMC, is chalcone derivat that have -3’ metoxy and -4’ hydroxyl 
phenyl. Although there are modifications to the structure, this compound still has a cytotoxic 
activity. But in this study, we did not compare the activity with the basic compound of chalcone. 
However the changes of the structure will affect its activity. Our present study showed that 
pHmMC increased apoptosis induction via G2/M arrest in MCF-7 cells. We proposed that NF-
κB survival system may play important roles in the antiproliferative activity of pHmMC in 
MCF-7cells, but this mechanism need to be explored further. However, the molecular 
mechanism of apoptotic induction and cell cycle need to be explored with more details.  
 
 
CONCLUSION AND SUGGESTION 
Based on the result, we concluded that  pHmMC has activity cytotoxic throught 
apoptosis induction and cell cycle arrest. This compound is potential to be develop as 
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